IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $175,507 | +1.1% | 16,495 | 0.0% | 0.00% | – |
| Q1 2023 | $173,527 | +84962.3% | 16,495 | 0.0% | 0.00% | – |
| Q4 2022 | $204 | -99.8% | 16,495 | +39.8% | 0.00% | – |
| Q3 2022 | $122,000 | -96.7% | 11,800 | -96.3% | 0.00% | -100.0% |
| Q2 2022 | $3,657,000 | -70.6% | 317,179 | -67.9% | 0.01% | -64.3% |
| Q1 2022 | $12,425,000 | +6.5% | 987,718 | -1.3% | 0.01% | +16.7% |
| Q4 2021 | $11,670,000 | -13.6% | 1,000,840 | -3.2% | 0.01% | -20.0% |
| Q3 2021 | $13,500,000 | – | 1,033,687 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |